HMPC Q&A Documents on Herbal Medicinal Products published
Recommendation
20/21 October 2026
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
On 12 May 2014, the EMA's HMPC (Committee on Herbal Medicinal Products) published the Questions & Answers document on (traditional) herbal medicinal products. The document also addresses herbal medicinal products which don't have a European tradition.
The Q&A document contains Questions & Answers about the following topics:
- Regulation of herbal medicinal products in the EU ( (Q&A 1 - 7)
- Specific provisions for traditional herbal medicinal products (Q&A 8 - 17)
- Type and role of monographs in the European framework (Q&A 18 - 21)
- Advice, procedures and relevant institutions (Q&A 22 - 24)
The table included in the answer to question 24 is particularly interesting. There you can find which authorities are responsible for individual decisions.
For further information please see the complete "Questions & Answers on the EU framework for (traditional) herbal medicinal products, including those from a non-European tradition".
Related GMP News
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
30.09.2026The Relationship between the BP and the Ph. Eur.
30.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
30.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence